Antibodies against factor VIII in patients with solid tumors: Successful treatment of cancer may suppress inhibitor formation

Haemostasis

Volumn 28, Issue 5, 1998, Pages 244-249

  Sallah, Sabah ^a   Singh, Paramjeet ^b   Hanrahan, L Robert ^b  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b EAST CAROLINA UNIVERSITY   (United States)

Author keywords

Bleeding; Cancer; Factor VIII; Inhibitor

Indexed keywords

ACTIVATED PROTHROMBIN COMPLEX; ANTINEOPLASTIC AGENT; BLOOD CLOTTING FACTOR 8 INHIBITOR; CISPLATIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; ETOPOSIDE; PREDNISONE; RECOMBINANT BLOOD CLOTTING FACTOR 8;

ADULT; AGED; ANTIBODY TITER; ARTICLE; BLEEDING; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; DIFFERENTIAL DIAGNOSIS; DISSEMINATED INTRAVASCULAR CLOTTING; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMAN; LUNG ADENOCARCINOMA; MALE; ORAL DRUG ADMINISTRATION; PANCREAS CANCER; PRIORITY JOURNAL; PROTHROMBIN TIME; RETROPERITONEAL HEMORRHAGE; SOLID TUMOR; STOMACH CANCER;

EID: 0032319416     PISSN: 03010147     EISSN: None     Source Type: Journal    
DOI: 10.1159/000022438     Document Type: Article

References (8)

1. Green D, Lechner K, A survey of 215 non-hemophilic patients with inhibitors to factor VIII. Thromb Haemost 1981;45:200-203.
2. Sallah S: Inhibitors to clotting factors. Ann Hematol 1997;75:1-7.
3. Green D, Rademaber AW, Briet E: A prospective, randomized trial of prednisone and cyclophosphamide in the treatment of patients with factor VIII autoantibodies. Thromb Haemost 1991;71:753-757.
4. Brox AG, Laryea H, Pelletier M: Successful treatment of acquired factor VIII inhibitors with cyclosporin. Am J Hematol 1998;57:87-88
5. Kasper CK, Aledort LM, Counts RB, Edson JR, Frantantoni J, Green D, Hampton JW, Hilgartner MW, Lazerson J, Levine PH, McMillan CW, Pool JG, Shapiro SS, Shulman NR, Van Eys J: A more uniform measurement of factor VIII inhibitors. Thromb Diath Haemorrh 1975;34:869-876.
6. Scandella D, Kessler C, Esmon P, Hurst D, Courter S, Gomperts E, Felch M, Prescott R: Epitope specificity and functional characterization of factor VIII inhibitors. Adv Exp Med Biol 1995;386:47-63.
7. Hutlin MB: Acquired inhibitors in malignant and non-malignant disease states. Am J Med 1991;91(suppl 5A):9S-13S.
8. Lottenberg R, Kentor TB, Kitchens CS: Acquired hemophilia: A natural history study of 16 patients with factor VIII inhibitors receiving little or no therapy. Arch Intern Med 1987;147:1077-1081.